Abstract:OBJECTIVES Low saphenous vein graft (SVG) patency has become the bottleneck in surgical revascularization. This study aimed to identify the predictors of early vein graft failure (VGF) after off-pump coronary bypass grafting (OPCAB). METHODS A total of 233 patients who had OPCAB were postoperatively evaluated by coronary computed tomography angiography. Logistic regression analyses were performed to detect the predictors of early VGF (FitzGibbon-B/O) at both the patient and the graft level. RESULTS Overall FitzGibbon-A patency of SVG at 1week after OPCAB was 94.1% (659/700). At the patient level, a patient who had at least 1 VGF was regarded as an event, and increased preoperative platelet count [odds ratio (OR) 9.848], quantity of perioperatively transfused red blood cells (RBC) (U, OR 1.544) and creatinine clearance rate (CCr) (ml/min, OR 1.037) were predictors of early VGF, whereas use of a left internal mammary artery graft was a protective factor (OR 0.348). At the graft level, when VGF was regarded as an event, increased preoperative platelet count (OR 17.450), CCr (ml/min, OR 1.034), quantity of perioperatively transfused RBC (U, OR 1.505) and endarterectomy (OR 5.499) were predictors of early VGF. Under the same circumstances, dual antiplatelet therapy (OR 0.419), recipient vessel diameter (mm, OR 0.052), graft run-off (ml/min, OR 0.949), preoperative RBC count (x10(12), OR 0.576) and a side-to-side (when compared with end-to-side) anastomosis (OR 0.276) were protective factors. The patency of SVGs sutured to vessels with a larger diameter (>1.5mm) was significantly higher than that of the others (96.6% vs 91.1%). SVGs with greater run-off (>25ml/min for each anastomosis) were significantly more patent than others (95.1% vs 88.7%). CONCLUSIONS Early SVG patency after OPCAB was satisfactory. Increased preoperative platelet count, more perioperative RBC transfusions and higher CCr were predictors of patients with early VGF, whereas use of a left internal mammary artery graft was a protective factor. Increased preoperative platelet count, higher CCr, more perioperative RBC transfusions and endarterectomy were predictors of VGF, whereas dual antiplatelet therapy, larger recipient vessel diameter, greater graft run-off, higher preoperative RBC count and side-to-side anastomosis were protective factors. Recipient diameter >1.5mm and graft run-off >25ml/min were cut-off values for detecting VGF.

Predictors of Vein Graft Disease Progression Between One Week and One Year after Surgical Coronary Revascularization: Impact of Secondary Prevention Medications

Predictors of early vein graft failure after off-pump coronary artery bypass grafting: angiocomputed tomographic results of 233 patients.

A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery

Relationship between intra-operative vein graft treatment with DuraGraft® or saline and clinical outcomes after coronary artery bypass grafting

The Role of Advanced Glycation End Products in Saphenous Vein Graft Failure

The effect of the A82G mutation in the MMP-12 gene and C634G mutation in the VEGF-A gene on the course of lower limb varicose veins and the risk of disease recurrence

Relationship between uric acid to albumin ratio and saphenous vein graft disease in patients with coronary artery bypass graft

Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting

Predictors of Disease Recurrence after Venoplasty and Stent Placement for May-Thurner Syndrome

Long-term results of percutaneous coronary intervention in no-touch vein grafts are significantly better than in conventional vein grafts

Association Between Proprotein Convertase Subtilisin/kexin Type 9 and Late Saphenous Vein Graft Disease after Coronary Artery Bypass Grafting: a Cross-Sectional Study

Relationship Between Plaque Composition by Virtual Histology Intravascular Ultrasound and Clinical Outcomes after Percutaneous Coronary Intervention in Saphenous Vein Graft Disease Patients: Study Protocol of a Prospective Cohort Study

Low Wall Shear Stress Is Associated with Saphenous Vein Graft Stenosis in Patients with Coronary Artery Bypass Grafting

Identification of important genes related to HVSMC proliferation and migration in graft restenosis based on WGCNA

C-Reactive Protein to Albumin Ratio in Patients With Saphenous Vein Graft Disease

Biomechanics and Mechanobiology of Saphenous Vein Grafts

Clinical outcomes and predictive factors of stent grafts treatment for symptomatic central venous obstruction in end stage kidney disease patients with arteriovenous access

The Role of TGF-β Signaling in Saphenous Vein Graft Failure after Peripheral Arterial Disease Bypass Surgery

Spatial Transcriptomic Profiling of Human Saphenous Vein Exposed to Ex Vivo Arterial Haemodynamics—Implications for Coronary Artery Bypass Graft Patency and Vein Graft Disease

Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts

In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial)